¿ Coulter Pharmaceutical Inc., of Palo Alto, Calif., appointed Kent Iverson vice president, manufacturing, Kay Slocum vice president, human resources, and Cathy Akiyama vice president, marketing.
¿ Diversa Corp., of San Diego, elected Jay Short CEO.
¿ Endocardial Solutions Inc., of Minneapolis, named Leota Pearson vice president, finance, and chief financial officer.
¿ EnSolve Biosystems Inc., of Research Triangle Park, N.C., named Tom Laundon vice president of business development.
¿ Epimmune Inc., of San Diego, appointed Mark Newman vice president, infectious disease program.
¿ Gene Logic Inc., of Gaithersburg, Md., named Mark Gessler president and chief operating officer.
¿ Genelabs Technologies Inc., of Redwood City, Calif., appointed to its board of directors J. Richard Crout, former director of the Bureau of Drugs (now the FDA¿s Center for Drug Evaluation and Research); Thomas Dewey Jr., senior investment banker and financial advisor with McFarland Dewey & Co. LLC, of New York; and Alan Kwan, a Houston attorney.
¿ Genovo Inc., of Sharon Hill, Pa., appointed Vaughn Himes vice president of process development and named Gary Kurtzman chief operating officer and chairman of the research and development committee.
¿ Hollis-Eden Pharmaceuticals Inc., of San Diego, appointed Christopher Reading vice president of scientific development.
¿ Inspire Pharmaceuticals Inc., of Durham, N.C., promoted Gregory Mossinghoff to vice president, corporate development.
¿ IntraBiotics Pharmaceuticals Inc., of Mountain View, Calif., appointed Peter Garcia chief financial officer.